My post before HIMSS talked about how jazzed (not jaded) I was to be attending my 20th HIMSS conference. Now […] The post HIMSS18 – A Cacophony, Not Yet a Symphony appeared first on Chilmark Research.
HIMSS18 Review 3 of 3 A decade of attending the annual HIMSS conference and I leave both excited and depressed. […] The post HIMSS18 – A Bipolar Experience appeared first on Chilmark Research.
HIMSS18 Review 2 of 3 By Matt Guldin and Brian Eastwood Having returned and (mostly) recovered from HIMSS18 in Las Vegas, […] The post HIMSS18: Care Management and Engagement appeared first on Chilmark Research.
HIMSS18 Review 1 of 3 By Ken Kleinberg, Brian Murphy, and Brian Edwards During Eric Schmidt’s opening keynote at HIMSS18, […] The post Give Us Your Data – Is it Really That Easy? appeared first on Chilmark Research.
In an age of recruitment by algorithm, many look at hiring as an exercise in mathematics. There’s sourcing ROI, funnel metrics, cycle times, and dozens of other calculations we’re told to examine to raise our level of success in the hiring arena. Show More Summary
An SEC fraud complaint paints a picture of the Theranos founder as an even smoother scamster than previously reported. But in settling the charges, Holmes is getting to keep her job.
We have accumulated a remarkable number of stories of people transiting the revolving door from high-level positions in health care corporations to high-level positions in health care policy or regulation for the Trump administration. Show More Summary
An online poll conducted by Harris Poll found that 69% of managers stated that they are uncomfortable communicating with employees. A whopping (but not surprising) 37% said they dislike giving direct feedback to an employee.
At 32, Cigall Kadoch is one of biology's rising stars. An assistant professor of pediatric oncology at the Dana Farber Cancer Institute, Kadoch runs a 24-person laboratory that delves into how altering the chemical packaging surrounding DNA can alter the way genes work.
Some more offerings in our fourth effort in these pages to get rid of this damned dander. It's still up! Here in the DOG Patch, D is for Dander, and the dander, in spite of smatterings of good new lately, has still got itself up.Vive le Québec! Nodbody's taking sides in Canadian separatism, if it's still brewing north of the border. Show More Summary
A dramatic gambit to bring down drug prices did the job. The problem? It's awful for the patients caught in the middle.
Sarepta Therapeutics says regulators at the Food and Drug Administration have told it they were open to reviewing its next experimental treatment for Duchenne muscular dystrophy, meaning that it could file an application for the new medicine by the end of this year.
There's nothing wrong with some well-placed rage, but the celebration over the jailing of Martin Shkreli ignores the fact that the loopholes that allowed him to jack up the price of drugs remain wide open.
The health insurer Cigna announced that it plans to buy pharmacy benefit manager Express Scripts for $54 billion. The big question: Will patients benefit, or will this just protect insurance company bottom lines?
Here are a few I have come across the last week or so. Note: Each link is followed by a title and a few paragraphs. For the full article click on the link above title of the article. Note also that full access to some links may require...Show More Summary
This appeared from the new New Zealand Health IT News Site A few days ago.Cross-Tasman tech leaders consider creating a health ‘passport’ Wednesday, 14 March 2018eHealthNews editor Rebecca McBethDevelopment of a consumer app that holds...Show More Summary
This popped up last week and caused me some amusement:Armenian PM instructs to introduce e-health system in 15 daysMarch 15, 2018 14:08YEREVAN. – Armenian Prime Minister Karen Karapetyan instructed to ensure full implementation of the...Show More Summary
Here are the results of the poll.Overall, What Do You Think Of The ADHA's Draft Framework For Action (2018-2022) - The Implementation Plan For Their Strategy? Great 2% (3) OK 5% (8) Neutral 19% (29) Not Much Good 44% (68) Poor Or Worse...Show More Summary
There would seem to be a momentum for new approvals brought on by a number of circumstances, not the least of which is the fact that last year saw a record number (47) of approvals for new molecular entities (NMEs), … Continue readi...
Set in its new home of the Francis Crick Institute, WIRED Health 2018 brought together world leaders and change-makers in cancer, aging, artificial intelligence, government, medical devices, and pharmaceuticals, to name but a few. Alongside...Show More Summary